Media-OutReach Newswire The United Laboratories and Novo Nordisk announce exclusive license agreement for UBT251, a GLP-1/GIP/glucagon triple receptor agonist
Media-OutReach Newswire Gynecomastia Affects All Ethnic Groups in Singapore, Amaris B. Clinic Study Reveals
Media-OutReach Newswire VinFuture Prize empowered the woman scientist Dr. Firdausi Qadri to give back to Bangladesh
Media-OutReach Newswire Medical Taiwan 2025: Explore Cutting-Edge AI, Smart Medical Solutions, and Wellness Innovations
Media-OutReach Newswire James Dyson Award 2025 seeks groundbreaking inventions from young engineers and scientists